Retention and distribution of two 99mTc -DTPA labelled vaginal dosage forms

International Journal of Pharmaceutics

Volumn 271, Issue 1-2, 2004, Pages 137-143

  Chatterton, Barry E ^a   Penglis, Stan ^a   Kovacs, Julie C ^a   Presnell, Bernardine ^a   Hunt, Barry ^b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b Connetics Australia Pty Ltd ^*  (Australia)

Author keywords

Gamma scintigraphy; Pharmacodynamics; Vaginal dose forms

Indexed keywords

CLOTRIMAZOLE; PENTETATE TECHNETIUM TC 99M; TRACER; AGENTS USED INTRAVAGINALLY; ANTIFUNGAL AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ANALYTIC METHOD; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; CROSSOVER PROCEDURE; DRUG ACTIVITY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG LABELING; DRUG RETENTION; EVALUATION; FEMALE; GAMMA SCINTIGRAPHY; GEL; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; MEAN RESIDENCE TIME; MENSTRUAL CYCLE; MICTURITION; NORMAL HUMAN; PREMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TIME; VAGINA; COMPARATIVE STUDY; METABOLISM;

ADULT; ANTIFUNGAL AGENTS; CLOTRIMAZOLE; CROSS-OVER STUDIES; FEMALE; HUMANS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M PENTETATE; VAGINA; VAGINAL CREAMS, FOAMS, AND JELLIES;

EID: 1142297661     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2003.11.006     Document Type: Article

References (11)

1. Asikoglu M., Ertan G., Ercan M.T., Duman Y. The release of isoconazole nitrate from different suppository bases: in vivo release of drug labelled with 99mTc in rabbits. J. Pharm. Pharmacol. 47:1995;717-720.
2. Barnhart K., Pretorius E.S., Stolpen A., Malamud D. Distribution of topical medication in the human vagina as imaged by magnetic resonance imaging. Fertil. Steril. 76:2001;189-195.
3. Brown J., Hooper G., Kenyon C.J., Haines S., Burt J., Humphries J.M., Newman S.P., Davis S.S., Sparrow R.A., Wilding I.R. Spreading and retention of vaginal formulations in post-menopausal women as assessed by gamma scintigraphy. Pharm. Res. 14:1997;1073-1078.
4. Chaudhuri T.K. Use of 99mTc-DTPA for measuring gastric emptying time. J. Nucl. Med. 15:1974;391-395.
5. Cicinelli E., Rubini G., De Ziegler D., Pinto V., Di Stefano M.G., Mele M. Absorption and preferential vagina-to-uterus distribution after vaginal administration of 99m-Tc-pertechnetate in postmenopausal women. Fertil. Steril. 76:2001;1108-1112.
6. Elias C.J., Coggins C., Alvarez F., Brache V., Fraser I.S., Lacarra M., Lahteenmaki P., Massai R., Mishell D.R. Jr., Phillips D.M., Salvatierra A.M. Colposcopic evaluation of vaginal gel formulation of iota-carageenan. Contraception. 56:1997;387-389.
7. 14C -flutimazole vaginal cream to post-menopausal women Arnzneimittelforschung. 48:1998;512-517.
8. Kunz G., Biel D., Deininger H., Wildt L., Leyendecker G. The dynamics of rapid sperm transport through the female genital tract: evidence from vaginal sonography of uterine peristalsis and hystersalpingoscintigraphy. Hum. Reprod. 11:1996;627-632.
9. Meseguer G., Gurney R., Buri P. In vivo evaluation of dosage forms: application of gamma scintigraphy to non-enteral routes of administration. J. Drug Target. 2:1994;269-288.
10. van der Bijl P., Thompson I.O., Squier C.A. Comparative permeability of human vaginal and buccal mucosa to water. Eur. J. Oral Sci. 105:1997;571-575.
11. Weinstein L., Henzel M.R., Tsina I.W. Vaginal retention of butoconazole nitrate cream: comparison of a standard and a sustained-release preparation. Clin. Ther. 16:1994;930-934.